Robinson Healthcare Limited – Trademark Portfolio
Entity Type: 99
Robinson Healthcare Limited holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include GAMGEE, INSTRAPAC, MANTAPROP, ANIMALINTEX, and INSTRASPEC CONTOUR XTRACT. The owner is based in Worksop, Nottinghamshire.
Unit 3, Lawn Road Industrial Estate
Carlton-in-Lindrick
Worksop, Nottinghamshire S81 9LB , GB
Showing of trademarks Trademarks
Trademark Classifications
Robinson Healthcare Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Robinson Healthcare Limited have?
Robinson Healthcare Limited has 7 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 cancelled.
What trademark classes does Robinson Healthcare Limited file in?
Robinson Healthcare Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 8 (Hand Tools). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Robinson Healthcare Limited's most well-known trademarks?
Robinson Healthcare Limited's registered trademark portfolio includes well-known marks such as GAMGEE, INSTRAPAC, MANTAPROP, ANIMALINTEX, and INSTRASPEC CONTOUR XTRACT. These are among 5 currently registered trademarks in the portfolio.
What is Robinson Healthcare Limited's trademark registration success rate?
Robinson Healthcare Limited has a 71% trademark registration rate, with 5 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.